Literature DB >> 24365752

Carcinoma in situ.

Nigel Bundred1, J Michael Dixon.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24365752     DOI： 10.1136/bmj.f3289

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  When Is Sentinel Node Biopsy Indicated in High-Risk Ductal Carcinoma in situ? Four Hundred Sixty-Eight Cases from Three Institutions.

Authors:  Tomás Cortadellas; Paula Argacha; Juan Acosta; Judith Jurado; Ricardo Peiró; Margarita Gomez; Xavier Gonzalez-Farré; Milagros Martinez; Miguel Luna; Vicente Peg; Antonio Gil-Moreno; Manel Xiberta
Journal:  Breast Care (Basel)       Date:  2021-03-30       Impact factor: 2.860

2.  Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.

Authors:  L M van Roozendaal; B Goorts; M Klinkert; K B M I Keymeulen; B De Vries; L J A Strobbe; C A P Wauters; Y E van Riet; E Degreef; E J T Rutgers; J Wesseling; M L Smidt
Journal:  Breast Cancer Res Treat       Date:  2016-04-15       Impact factor: 4.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.